Sernova (SVA) Stock Price, News & Analysis

Company Overview

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.

Key Stats

• Today's Range: C$0.17 to C$0.19
• 50-Day Range: C$0.14 to C$0.19
• 52-Week Range: C$0.12 to C$0.23
• Volume: 250,626 shs
• Average Volume: 117,216 shs
• Market Capitalization: C$60.85 million
• P/E Ratio: N/A
• Dividend Yield: 7.86%
• Price Target: N/A
• Consensus Rating: N/A

SVA Stock Analysis - Frequently Asked Questions

How have SVA shares performed this year?

Sernova's stock was trading at C$0.13 on January 1st, 2026. Since then, SVA stock has increased by 34.6% and is now trading at C$0.18.

How were Sernova's earnings last quarter?

Sernova Corp. (TSE:SVA) issued its quarterly earnings data on Friday, March, 13th. The company reported $0.01 EPS for the quarter.

How do I buy shares of Sernova?

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Sernova own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova Biotherapeutics (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC).

Company Calendar

• Last Earnings: 3/13/2026
• Today: 5/05/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: TSE:SVA
• CIK: N/A
• Web: www.sinovacbio.com
• Phone: 861082890088
• Fax: N/A
• Employees: 1,959
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$35.70 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: 51.72%
• Return on Assets: -119.26%

Debt

• Debt-to-Equity Ratio: -68.55
• Current Ratio: 0.03
• Quick Ratio: 18.11

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$0.03 per share
• Price / Cash Flow: 6.15
• Book Value: C($0.08) per share
• Price / Book: -2.30

Miscellaneous

• Outstanding Shares: 347,726,000
• Free Float: N/A
• Market Cap: C$60.85 million
• Optionable: Not Optionable
• Beta: -0.28